• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Thyrotropin Receptor (TSHR) Recombinant Protein

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS1085783

MBS1085783 is a recombinant protein targeting TSHR. Also known as Recombinant human Thyrotropin receptor. Host: E.coli. More details

$1510 / 1 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Thyrotropin receptor (TSHR), Recombinant Protein
Full Product Name
Recombinant human Thyrotropin receptor
Product Gene Name
Product Synonym Names
Thyroid-stimulating hormone receptor; TSH-R
Sequence
GMGCSSPPCE CHQEEDFRVT CKDIQRIPSL PPSTQTLKLI ETHLRTIPSH AFSNLPNISR IYVSIDVTLQ QLESHSFYNL SKVTHIEIRN TRNLTYIDPD ALKELPLLKF LGIFNTGLKM FPDLTKVYST DIFFILEITD NPYMTSIPVN AFQGLCNETL TLKLYNNGFT SVQGYAFNGT KLDAVYLNKN KYLTVIDKDA FGGVYSGPSL LDVSQTSVTA LPSKGLEHLK ELIARNTWTL KKLPLSLSFL HLTRADLSYP SHCCAFKNQK KIRGILESLM CNESSMQSLR QRKSVNALNS PLHQEYEENL GDSIVGYKEK SKFQDTHNNA HYYVFFEEQE DEIIGFGQEL KNP
Host
E.coli
Form/Format
10 mM Tris-HCl, 1 mM EDTA, pH 8.0, 50% glycerol
Purity/Purification
85%±5% by SDS-PAGE
Preparation and Storage
Aliquot and store at < -20°C. Avoid repeated freeze/thaw cycles.
Sequence Positions
21-413aa
OMIM
275200
3D Structure
ModBase 3D Structure for P16473
Tag Info
his-tag
Expression Region
21-413aa
Appearance
Clear Solution
ISO Certification
Manufactured in an ISO 9001:2015 Certified Laboratory.
Applications Tested/Suitable for TSHR recombinant protein
Calibrator or standard

SDS-Page of TSHR recombinant protein

Recombinant human Thyrotropin receptor
His-tagged
Yeast derived
TSHR Recombinant Protein – Cat# MBS1085783

Product References and Citations for TSHR recombinant protein

Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor.Nagayama Y., Kaufman K.D., Seto P., Rapoport B.Biochem. Biophys. Res. Commun. 165:1184-1190(1989) Cloning, sequencing and expression of the human thyrotropin (TSH) receptor evidence for binding of autoantibodies.Libert F., Lefort A., Gerard C., Parmentier M., Perret J., Ludgate M., Dumont J.E., Vassart G.Biochem. Biophys. Res. Commun. 165:1250-1255(1989) Cloning, sequencing and expression of human TSH receptor.Misrahi M., Loosfelt H., Atger M., Sar S., Guiochon-Mantel A., Milgrom E.Biochem. Biophys. Res. Commun. 166:394-403(1990) Isolation of TSH and LH/CG receptor cDNAs from human thyroid regulation by tissue specific splicing.Frazier A.L., Robbins L.S., Stork P.J., Sprengel R., Segaloff D.L., Cone R.D.Mol. Endocrinol. 4:1264-1276(1990) Cloning and sequencing of a 1.3 KB variant of human thyrotropin receptor mRNA lacking the transmembrane domain.Graves P.N., Tomer Y., Davies T.F.Biochem. Biophys. Res. Commun. 187:1135-1143(1992) Molecular cloning and sequencing of an alternatively spliced form of the human thyrotropin receptor transcript.Takeshita A., Nagayama Y., Fujiyama K., Yokoyama N., Namba H., Yamashita S., Izumi M., Nagataki S.Biochem. Biophys. Res. Commun. 188:1214-1219(1992) cDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (www.cdna.org) .Kopatz S.A., Aronstam R.S., Sharma S.V. The DNA sequence and analysis of human chromosome 14.Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C., Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A., Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H., Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T., Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B., Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D., Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R., Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S., Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C., Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S., Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C., Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P., Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M., Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V., Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J., Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F., Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F., Waterston R., Hood L., Weissenbach J.Nature 421:601-607(2003) Purification and characterization of a soluble bioactive amino-terminal extracellular domain of the human thyrotropin receptor.Cornelis S., Uttenweiler-Joseph S., Panneels V., Vassart G., Costagliola S.Biochemistry 40:9860-9869(2001) Thyrostimulin, a heterodimer of two new human glycoprotein hormone subunits, activates the thyroid-stimulating hormone receptor.Nakabayashi K., Matsumi H., Bhalla A., Bae J., Mosselman S., Hsu S.Y., Hsueh A.J.W.J. Clin. Invest. 109:1445-1452(2002) Thyrotropin receptor trafficking relies on the hScrib-betaPIX-GIT1-ARF6 pathway.Lahuna O., Quellari M., Achard C., Nola S., Meduri G., Navarro C., Vitale N., Borg J.-P., Misrahi M.EMBO J. 24:1364-1374(2005) Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions.Jiang X., Dreano M., Buckler D.R., Cheng S., Ythier A., Wu H., Hendrickson W.A., el Tayar N.Structure 3:1341-1353(1995) Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody.Sanders J., Chirgadze D.Y., Sanders P., Baker S., Sullivan A., Bhardwaja A., Bolton J., Reeve M., Nakatake N., Evans M., Richards T., Powell M., Miguel R.N., Blundell T.L., Furmaniak J., Smith B.R.Thyroid 17:395-410(2007) Further studies of genetic susceptibility to Graves' disease in a Russian population.Chistiakov D.A., Savost'anov K.V., Turakulov R.I., Petunina N., Balabolkin M.I., Nosikov V.V.Med. Sci. Monit. 8:CR180-CR184(2002) A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease.Ban Y., Greenberg D.A., Concepcion E.S., Tomer Y.Thyroid 12:1079-1083(2002) Association of Graves' disease with intragenic polymorphism of the thyrotropin receptor gene in a cohort of Singapore patients of multi-ethnic origins.Ho S.-C., Goh S.-S., Khoo D.H.Thyroid 13:523-528(2003) The human thyrotropin receptor is highly mutable a review of gain-of-function mutations.Farid N.R., Kascur V., Balazs C.Eur. J. Endocrinol. 143:25-30(2000) A somatic point mutation in a putative ligand binding domain of the TSH receptor in a patient with autoimmune hyperthyroidism.Heldin N.-E., Gustavsson B., Westermark K., Westermark B.J. Clin. Endocrinol. Metab. 73:1374-1376(1991) Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas.Parma J., Duprez L., van Sande J., Cochaux P., Gervy C., Mockel J., Dumont J.E., Vassart G.Nature 365:649-651(1993) A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy.Bahn R.S., Dutton C.M., Heufelder A.E., Sarkar G.J. Clin. Endocrinol. Metab. 78:256-260(1994) Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy.Porcellini A., Ciullo I., Laviola L., Amabile G., Fenzi G., Avvedimento V.E.J. Clin. Endocrinol. Metab. 79:657-661(1994) Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid.Paschke R., Tonacchera M., van Sande J., Parma J., Vassart G.J. Clin. Endocrinol. Metab. 79:1785-1789(1994) Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism.Duprez L., Parma J., van Sande J., Allgeier A., Leclere J., Schvartz C., Delisle M.-J., Decoulx M., Orgiazzi J., Dumont J.E., Vassart G.Nat. Genet. 7:396-401(1994) Functional analysis of a variant of the thyrotropin receptor gene in a family with Graves' disease.Gustavsson B., Eklof C., Westermark K., Westermark B., Heldin N.-E.Mol. Cell. Endocrinol. 111:167-173(1995) Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene.Kopp P., van Sande J., Parma J., Duprez L., Gerber H., Joss E., Jameson J.L., Dumont J.E., Vassart G.N. Engl. J. Med. 332:150-154(1995) Resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene.Sunthornthepvarakul T., Gottschalk M.E., Hayashi Y., Refetoff S.N. Engl. J. Med. 332:155-160(1995) Point mutations in the thyrotropin receptor in human thyroid tumors.Ohno M., Endo T., Ohta K., Gunji K., Onaya T.Thyroid 5:97-100(1995) Normal function in vivo of a homozygotic polymorphism in the human thyrotropin receptor.Cuddihy R.M., Bryant W.P., Bahn R.S.Thyroid 5:255-257(1995) Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia.Tonacchera M., van Sande J., Cetani F., Swillens S., Schvartz C., Winiszewski P., Portmann L., Dumont J.E., Vassart G., Parma J.J. Clin. Endocrinol. Metab. 81:547-554(1996) A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism.de Roux N., Polak M., Couet J., Leger J., Czernichow P., Milgrom E., Misrahi M.J. Clin. Endocrinol. Metab. 81:2023-2026(1996) Four families with loss of function mutations of the thyrotropin receptor.de Roux N., Misrahi M., Brauner R., Houang M., Carel J.-C., Granier M., Le Bouc Y., Ghinea N., Boumedienne A., Toublanc J.E., Milgrom E.J. Clin. Endocrinol. Metab. 81:4229-4235(1996) Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma.Russo D., Tumino S., Arturi F., Vigneri P., Grasso G., Pontecorvi A., Filetti S., Belfiore A.J. Clin. Endocrinol. Metab. 82:735-738(1997) Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH.Clifton-Bligh R.J., Gregory J.W., Ludgate M., John R., Persani L., Asteria C., Beck-Peccoz P., Chatterjee V.K.K.J. Clin. Endocrinol. Metab. 82:1094-1100(1997) Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas.Parma J., Duprez L., van Sande J., Hermans J., Rocmans P., van Vliet G., Costagliola S., Rodien P., Dumont J.E., Vassart G.J. Clin. Endocrinol. Metab. 82:2695-2701(1997) Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism.Biebermann H., Schoeneberg T., Krude H., Schultz G., Gudermann T., Grueters A.J. Clin. Endocrinol. Metab. 82:3471-3480(1997) Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene.Holzapfel H.P., Wonerow P., von Petrykowski W., Henschen M., Scherbaum W.A., Paschke R.J. Clin. Endocrinol. Metab. 82:3879-3884(1997) Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism.Fuhrer D., Wonerow P., Willgerodt H., Paschke R.J. Clin. Endocrinol. Metab. 82:4234-4238(1997) Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland.Abramowicz M.J., Duprez L., Parma J., Vassart G., Heinrichs C.J. Clin. Invest. 99:3018-3024(1997) Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor.Kopp P., Muirhead S., Jourdain N., Gu W.X., Jameson J.L., Rodd C.J. Clin. Invest. 100:1634-1639(1997) Congenital nonautoimmune hyperthyroidism in a nonidentical twin caused by a sporadic germline mutation in the thyrotropin receptor gene.Kopp P., Jameson J.L., Roe T.F.Thyroid 7:765-770(1997) Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor.Grueters A., Schoeneberg T., Biebermann H., Krude H., Krohn H.P., Dralle H., Gudermann T.J. Clin. Endocrinol. Metab. 83:1431-1436(1998) Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin.Rodien P., Bremont C., Raffin Sanson M.-L., Parma J., van Sande J., Costagliola S., Luton J.-P., Vassart G., Duprez L.N. Engl. J. Med. 339:1823-1826(1998) A germline mutation of the thyrotropin receptor gene associated with thyrotoxicosis and mitral valve prolapse in a Chinese family.Khoo D.H.C., Parma J., Rajasoorya C., Ho S.C., Vassart G.J. Clin. Endocrinol. Metab. 84:1459-1462(1999) Germline polymorphism of codon 727 of human thyroid-stimulating hormone receptor is associated with toxic multinodular goiter.Gabriel E.M., Bergert E.R., Grant C.S., van Heerden J.A., Thompson G.B., Morris J.C.J. Clin. Endocrinol. Metab. 84:3328-3335(1999) A Val 677 activating mutation of the thyrotropin receptor in a Hurthle cell thyroid carcinoma associated with thyrotoxicosis.Russo D., Wong M.G., Costante G., Chiefari E., Treseler P.A., Arturi F., Filetti S., Clark O.H.Thyroid 9:13-17(1999) A novel thyrotropin receptor mutation in an infant with severe thyrotoxicosis.Esapa C.T., Duprez L., Ludgate M., Mustafa M.S., Kendall-Taylor P., Vassart G., Harris P.E.Thyroid 9:1005-1010(1999) A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient.Kosugi S., Hai N., Okamoto H., Sugawa H., Mori T.Eur. J. Endocrinol. 143:471-477(2000) Analysis of the genetic variability of the 1st (CCC/ACC, P52T) and the 10th exons (bp 1012-1704) of the TSH receptor gene in Graves' disease.Kaczur V., Takacs M., Szalai C., Falus A., Nagy Z., Berencsi G., Balazs C.Eur. J. Immunogenet. 27:17-23(2000) Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin evidence for a new inactivating mutation of the TSH receptor gene.Tonacchera M., Agretti P., Pinchera A., Rosellini V., Perri A., Collecchi P., Vitti P., Chiovato L.J. Clin. Endocrinol. Metab. 85:1001-1008(2000) Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter.Tonacchera M., Agretti P., Chiovato L., Rosellini V., Ceccarini G., Perri A., Viacava P., Naccarato A.G., Miccoli P., Pinchera A., Vitti P.J. Clin. Endocrinol. Metab. 85:2270-2274(2000) Lack of association of nonautoimmune hyperfunctioning thyroid disorders and a germline polymorphism of codon 727 of the human thyrotropin receptor in a European Caucasian population.Muehlberg T., Herrmann K., Joba W., Kirchberger M., Heberling H.-J., Heufelder A.E.J. Clin. Endocrinol. Metab. 85:2640-2643(2000) A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH.Russo D., Betterle C., Arturi F., Chiefari E., Girelli M.E., Filetti S.J. Clin. Endocrinol. Metab. 85:4238-4242(2000) Constitutively activating TSH-receptor mutations as a molecular cause of non-autoimmune hyperthyroidism in childhood.Biebermann H., Schoeneberg T., Krude H., Gudermann T., Grueters A.Langenbecks Arch. Surg. 385:390-392(2000) Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene.Tonacchera M., Agretti P., Rosellini V., Ceccarini G., Perri A., Zampolli M., Longhi R., Larizza D., Pinchera A., Vitti P., Chiovato L.Thyroid 10:859-863(2000) A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism.Camacho P., Gordon D., Chiefari E., Yong S., DeJong S., Pitale S., Russo D., Filetti S.Thyroid 10:1009-1012(2000) Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism.Fuhrer D., Warner J., Sequeira M., Paschke R., Gregory J.W., Ludgate M.Thyroid 10:1035-1041(2000) A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism.Alberti L., Proverbio M.C., Costagliola S., Weber G., Beck-Peccoz P., Chiumello G., Persani L.Eur. J. Endocrinol. 145:249-254(2001) The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism.Biebermann H., Schoeneberg T., Hess C., Germak J., Gudermann T., Grueters A.J. Clin. Endocrinol. Metab. 86:4429-4433(2001) Detection of thyroid-stimulating hormone receptor and G(s) alpha mutations in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis.Truelzsch B., Krohn K., Wonerow P., Chey S., Holzapfel H.-P., Ackermann F., Fuehrer D., Paschke R.J. Mol. Med. 78:684-691(2001) Novel inactivating missense mutations in the thyrotropin receptor gene in Japanese children with resistance to thyrotropin.Nagashima T., Murakami M., Onigata K., Morimura T., Nagashima K., Mori M., Morikawa A.Thyroid 11:551-559(2001) Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population.Vanvooren V., Uchino S., Duprez L., Costa M.J., Vandekerckhove J., Parma J., Vassart G., Dumont J.E., van Sande J., Noguchi S.Eur. J. Endocrinol. 147:287-291(2002) Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism.Alberti L., Proverbio M.C., Costagliola S., Romoli R., Boldrighini B., Vigone M.C., Weber G., Chiumello G., Beck-Peccoz P., Persani L.J. Clin. Endocrinol. Metab. 87:2549-2555(2002) Functional significance of the thyrotropin receptor germline polymorphism D727E.Sykiotis G.P., Neumann S., Georgopoulos N.A., Sgourou A., Papachatzopoulou A., Markou K.B., Kyriazopoulou V., Paschke R., Vagenakis A.G., Papavassiliou A.G.Biochem. Biophys. Res. Commun. 301:1051-1056(2003) Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects.Peeters R.P., van Toor H., Klootwijk W., de Rijke Y.B., Kuiper G.G.J.M., Uitterlinden A.G., Visser T.J.J. Clin. Endocrinol. Metab. 88:2880-2888(2003) TSH receptor and Gs(alpha) genetic analysis in children with Down's syndrome and subclinical hypothyroidism.Tonacchera M., Perri A., De Marco G., Agretti P., Montanelli L., Banco M.E., Corrias A., Bellone J., Tosi M.T., Vitti P., Martino E., Pinchera A., Chiovato L.J. Endocrinol. Invest. 26:997-1000(2003) Congenital hypothyroidism and apparent athyreosis with compound heterozygosity or compensated hypothyroidism with probable hemizygosity for inactivating mutations of the TSH receptor.Park S.-M., Clifton-Bligh R.J., Betts P., Chatterjee V.K.K.Clin. Endocrinol. (Oxf.) 60:220-227(2004) Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation.Vaidya B., Campbell V., Tripp J.H., Spyer G., Hattersley A.T., Ellard S.Clin. Endocrinol. (Oxf.) 60:711-718(2004) Low prevalence of thyrotropin receptor mutations in a large series of subjects with sporadic and familial nonautoimmune subclinical hypothyroidism.Tonacchera M., Perri A., De Marco G., Agretti P., Banco M.E., Di Cosmo C., Grasso L., Vitti P., Chiovato L., Pinchera A.J. Clin. Endocrinol. Metab. 89:5787-5793(2004) +Additional computationally mapped references.<p>Provides general information on the entry.

Other Notes

Small volumes of TSHR recombinant protein vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for TSHR. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
NCBI Accession #
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
thyrotropin receptor isoform 1
NCBI Official Synonym Full Names
thyroid stimulating hormone receptor
NCBI Official Symbol
TSHR
NCBI Official Synonym Symbols
LGR3; CHNG1; hTSHR-I
UniProt Protein Name
Thyrotropin receptor
UniProt Synonym Protein Names
Thyroid-stimulating hormone receptor; TSH-R
Protein Family
UniProt Gene Name
TSHR
UniProt Synonym Gene Names
LGR3; TSH-R
UniProt Entry Name
TSHR_HUMAN
NCBI Protein Information
thyrotropin receptor

NCBI Summary for TSHR

The protein encoded by this gene is a membrane protein and a major controller of thyroid cell metabolism. The encoded protein is a receptor for thyrothropin and thyrostimulin, and its activity is mediated by adenylate cyclase. Defects in this gene are a cause of several types of hyperthyroidism. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Show more

UniProt Comments for TSHR

TSHR: Receptor for thyrothropin. Plays a central role in controlling thyroid cell metabolism. The activity of this receptor is mediated by G proteins which activate adenylate cyclase. Also acts as a receptor for thyrostimulin (GPA2+GPB5). Defects in TSHR are found in patients affected by hyperthyroidism with different etiologies. Somatic, constitutively activating TSHR mutations and/or constitutively activating G(s)alpha mutations have been identified in toxic thyroid nodules (TTNs) that are the predominant cause of hyperthyroidism in iodine deficient areas. These mutations lead to TSH independent activation of the cAMP cascade resulting in thyroid growth and hormone production. TSHR mutations are found in autonomously functioning thyroid nodules (AFTN), toxic multinodular goiter (TMNG) and hyperfunctioning thyroid adenomas (HTA). TMNG encompasses a spectrum of different clinical entities, ranging from a single hyperfunctioning nodule within an enlarged thyroid, to multiple hyperfunctioning areas scattered throughout the gland. HTA are discrete encapsulated neoplasms characterized by TSH- independent autonomous growth, hypersecretion of thyroid hormones, and TSH suppression. Defects in TSHR are also a cause of thyroid neoplasms (papillary and follicular cancers). Autoantibodies against TSHR are directly responsible for the pathogenesis and hyperthyroidism of Graves disease. Antibody interaction with TSHR results in an uncontrolled receptor stimulation. Defects in TSHR are the cause of congenital hypothyroidism non-goitrous type 1 (CHNG1); also known as congenital hypothyroidism due to TSH resistance. CHNG1 is a non-autoimmune condition characterized by resistance to thyroid- stimulating hormone (TSH) leading to increased levels of plasma TSH and low levels of thyroid hormone. CHNG1 presents variable severity depending on the completeness of the defect. Most patients are euthyroid and asymptomatic, with a normal sized thyroid gland. Only a subset of patients develop hypothyroidism and present a hypoplastic thyroid gland. Defects in TSHR are the cause of familial gestational hyperthyroidism (HTFG). HTFG is a condition characterized by abnormally high levels of serum thyroid hormones occurring during early pregnancy. Defects in TSHR are the cause of hyperthyroidism non- autoimmune (HTNA). It is a condition characterized by abnormally high levels of serum thyroid hormones, thyroid hyperplasia, goiter and lack of anti-thyroid antibodies. Typical features of Graves disease such as exophthalmia, myxedema, antibodies anti-TSH receptor and lymphocytic infiltration of the thyroid gland are absent. Belongs to the G-protein coupled receptor 1 family. FSH/LSH/TSH subfamily. 2 isoforms of the human protein are produced by alternative splicing.

Protein type: Receptor, GPCR; GPCR, family 1; Membrane protein, integral; Membrane protein, multi-pass

Chromosomal Location of Human Ortholog: 14q31

Cellular Component: integral to plasma membrane; plasma membrane; receptor complex

Molecular Function: peptide receptor activity, G-protein coupled; protein binding; thyroid-stimulating hormone receptor activity

Biological Process: adenylate cyclase activation; cell-cell signaling; G-protein coupled receptor protein signaling pathway; G-protein signaling, adenylate cyclase activating pathway; G-protein signaling, coupled to cyclic nucleotide second messenger; hormone-mediated signaling; positive regulation of cell proliferation

Disease: Hyperthyroidism, Familial Gestational; Hyperthyroidism, Nonautoimmune; Hypothyroidism, Congenital, Nongoitrous, 1
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000